185 related articles for article (PubMed ID: 17475835)
1. Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha in antiapoptotic effect of CpG-B oligodeoxynucleotide.
Kuo CC; Liang CM; Lai CY; Liang SM
J Immunol; 2007 May; 178(10):6100-8. PubMed ID: 17475835
[TBL] [Abstract][Full Text] [Related]
2. Role of Hsp90 in CpG ODN mediated immunostimulation in avian macrophages.
Bhat A; Gomis S; Potter A; Tikoo SK
Mol Immunol; 2010 Mar; 47(6):1337-46. PubMed ID: 20096933
[TBL] [Abstract][Full Text] [Related]
3. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
[TBL] [Abstract][Full Text] [Related]
4. CpG-B oligodeoxynucleotide promotes cell survival via up-regulation of Hsp70 to increase Bcl-xL and to decrease apoptosis-inducing factor translocation.
Kuo CC; Liang SM; Liang CM
J Biol Chem; 2006 Dec; 281(50):38200-7. PubMed ID: 17046822
[TBL] [Abstract][Full Text] [Related]
5. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
Assaf A; Esteves H; Curnow SJ; Browning MJ
Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
Arunkumar N; Liu C; Hang H; Song W
Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
[TBL] [Abstract][Full Text] [Related]
7. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
8. Class I and III phosphatidylinositol 3'-kinase play distinct roles in TLR signaling pathway.
Kuo CC; Lin WT; Liang CM; Liang SM
J Immunol; 2006 May; 176(10):5943-9. PubMed ID: 16670302
[TBL] [Abstract][Full Text] [Related]
9. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
Adamsson J; Lindblad M; Lundqvist A; Kelly D; Holmgren J; Harandi AM
J Immunol; 2006 Apr; 176(8):4902-13. PubMed ID: 16585586
[TBL] [Abstract][Full Text] [Related]
10. Pivotal role of ADP-ribosylation factor 6 in Toll-like receptor 9-mediated immune signaling.
Wu JY; Kuo CC
J Biol Chem; 2012 Feb; 287(6):4323-34. PubMed ID: 22170068
[TBL] [Abstract][Full Text] [Related]
11. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
[TBL] [Abstract][Full Text] [Related]
13. Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.
Millson SH; Truman AW; Rácz A; Hu B; Panaretou B; Nuttall J; Mollapour M; Söti C; Piper PW
FEBS J; 2007 Sep; 274(17):4453-63. PubMed ID: 17681020
[TBL] [Abstract][Full Text] [Related]
14. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
15. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
Roda JM; Parihar R; Carson WE
J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
[TBL] [Abstract][Full Text] [Related]
16. Effects of CpG-B ODN on the protein expression profile of swine PBMC.
Nagarajan G; Kuo CC; Liang CM; Chen CM; Liang SM
Vet Res; 2007; 38(6):795-808. PubMed ID: 17727805
[TBL] [Abstract][Full Text] [Related]
17. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
18. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
[TBL] [Abstract][Full Text] [Related]
19. CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.
Liu YC; Gray RC; Hardy GA; Kuchtey J; Abbott DW; Emancipator SN; Harding CV
J Immunol; 2010 Apr; 184(7):3367-76. PubMed ID: 20181884
[TBL] [Abstract][Full Text] [Related]
20. TRAIL is involved in CpG ODN-mediated anti-apoptotic signals.
Lim EJ; Park DW; Jeong TW; Chin BR; Bae YS; Baek SH
Oncol Rep; 2012 Apr; 27(4):1213-8. PubMed ID: 22159760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
